Global Breast Cancer Market 2013: Latest Industry Analysis, Size, Share, Growth, Trends and Forecast Research Report Available at Marketresearchreports.biz

News provided by

Market Research Reports

Jul 13, 2013, 01:30 ET

Albany, NY (PRWEB) July 13, 2013 -- Riding on the back of evolving technological environment, the global healthcare and pharmaceutical industry is now surmounting new acmes. The growth of the respective sector is further filliped by the increasing number of health related issues surfacing on account of changing lifestyle and incessantly evolving surroundings.

To cater to the necessity of better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved diagnostic technologies and treatment therapies, especially in the field of breast cancer treatment.

‘Cancer’ is the result of any mutation or abnormal changes in the genes which are responsible for regulating the growth of cells and keeping them healthy. The tumor formed due to cancer can be either ‘benign’ (not dangerous) or ‘malignant’ (potentially dangerous). ‘Breast cancer’ is a malignant tumor that has developed from cells in the breast. Typically breast cancer either begins in the cells of the lobules (milk-producing glands), or the ducts (the passages that drain milk from the lobules to the nipple).

The stages of breast cancer are crucial as they only determine the type of treatment method and the extent to which the disease can be cured.

To Read The Complete Report with TOC : http://www.marketresearchreports.biz/analysis-details/breast-cancer-market-report-2013-edition

On the diagnosis front, mammography is believed to diagnose 85% to 90% of breast cancers in women over 50, and is capable of discovering a lesion one to four years before a lump can be felt. In case of patients with dense breast tissue, breast implants or patients who are breastfeeding, mammography cannot produce clear images; therefore, in such cases, ultrasound or MRI is recommended. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, the first method to be used is surgical, followed by hormone therapy, chemo therapy or radiation therapy.

To Buy a Copy Of This Report: http://www.marketresearchreports.biz/analysis/169851

After lung cancer, breast cancer is the 2nd most prevalent type of cancer and 5th most common cause of cancer deaths on global scale. Over one million new cases of breast cancer are diagnosed every year world over.

Table of Content

1. Breast Cancer: Overview
1.1 Types of Breast Cancer
1.2 Risk Factors
1.3 Symptoms of Breast Cancer
1.4 Diagnosis and Treatment of Breast Cancer
1.4.1 Breast Cancer Screening and Diagnostic Measures
1.4.2 Breast Cancer Treatment Regime

2. Market Size
2.1 Breast Cancer Statistics
-New Cases
-Estimated Deaths
2.2 Breast Cancer Market Structure

  • Therapeutics Market

-Diagnostics Market
-Market Segmentation
2.2.1 Regional Breast Cancer Markets
-The US
-Brazil
-India
2.3 Breast Cancer Therapeutics Model

3. Market Dynamics
3.1 Industry Trends and Developments
3.1.1 Successive Clinical Trials and Product Development
3.2 Growth Drivers
3.2.1 Increasing Prevalence of Cancer
3.2.2 Increasing Use of Tobacco and Alcohol
3.2.3 Expanding Obese Population
3.2.4 Rising Demand for Better Healthcare Options
3.2.5 Growing Female Population (+45 Years)
3.2.6 Higher Spending on Medicines
3.3 Challenges
3.3.1 Rising Costs of Treatment
3.3.2 Stringent Regulatory Measures
3.3.3 Adverse Effects of the Treatment
3.3.4 Mounting Price Pressure

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz
Website: http://www.marketresearchreports.biz/
Blog : http://articlesnarticles.blogspot.com/
Blog: http://marketsbuzz.wordpress.com/

Michell Thoras, Market Research Reports, http://www.marketresearchreports.biz/, 1-518-618-1030, [email protected]